DCM Shriram Fine Chemicals Ltd

DCM Shriram Fine Chemicals Limited informed the BSE Ltd and National Stock Exchange of India Ltd that Venkata Rama Subbu Behara resigned as an Independent Director, effective September 8, 2026, due to recent changes in the board structure. Behara currently serves as a director in MTAR Technologies Limited and Gabriel India Limited, holding committee positions in both companies, including chairman of the Stakeholders’ Relationship Committee at MTAR Technologies and member of the Nomination and Remuneration Committee at Gabriel India.

DCM Shriram Fine Chemicals Limited informed the BSE Ltd and National Stock Exchange of India Ltd that Venkata Rama Subbu Behara resigned as an Independent Director, effective September 8, 2026, due to recent changes in the Board’s structure. Behara currently serves as a director in MTAR Technologies Limited and Gabriel India Limited, holding committee positions in both companies, including chairman of the Stakeholders’ Relationship Committee at MTAR Technologies and member of the Nomination and Remuneration Committee at Gabriel India.

Urvashi Tilakdhar is acquiring 15,26,766 equity shares, representing 1.76% of DCM Shriram Fine Chemicals Limited, from Akshay Dhar and 15,26,765 equity shares, also 1.76%, from Aditi Dhar, for a total of 3.52% of the company's share capital, as part of an inter-family gift. The acquisition, scheduled for August 24, 2026, will bring Tilakdhar’s total shareholding to 4,35,90,115 shares, or 50.11% of the company's capital.

DCM Shriram Fine Chemicals Ltd share price remained flat to Rs 25.56 after the company's net profit plunged by 167.62% to Rs 2.59 crore, while revenue from operations slipped slightly by 2.49% to Rs 90.18 crore in Q2FY26 over Q1FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.1 lakh crore, rallying 15.03%. It has improved by 1.55% over last one week and heading higher by 13.66% in last one month while the market capitalization of DCM Shriram Fine Chemicals Ltd has marginally improved by 2.03% and 9.84% in the same period respectively. Profit before tax (PBT) of DCM Shriram Fine Chemicals Ltd stood at Rs 3.77 crore in Q2 FY26, crashing by 35.00% year-on-year, and tumbling by 183.41% quarter-on-quarter. EBITDA came in at Rs 4 crore, nosediving by 36.68% YoY and tanking 224.31% sequentially. Total expenses dropped by 10.26% to Rs 87.63 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 60.68 crore, posting a minor increase of 6.59% YoY, while employee benefits expense was at Rs 12.21 crore, seeing a marginal contraction of 1.61% YoY. For the TTM ended FY26, revenue from operations contracted by 10.38% to Rs 382.64 crore, while net profit tumbled by 118.46% to Rs 3.54 crore, compared to previous TTM. EBITDA surged by 2769% to Rs 0.46 crore, and PBT tanked by 112.12% to Rs 3.14 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 16.07 crore in FY26, as against Rs 14.23 crore in FY25.

DCM Shriram Fine Chemicals Ltd share price inched up 2% to Rs 25.56. The Company's net profit plunged by 167.62% to Rs 2.59 crore, while revenue from operations softened by 2.49% to Rs 90.18 crore in Q2FY26 over Q1FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.11 lakh crore, expanding by 15.04%. It has marginally improved by 1% over last one week and moving up by 13.02% in last one month while the market capitalization of DCM Shriram Fine Chemicals Ltd has improved by 0.39% and 7.63% in the same period respectively. Profit before tax (PBT) of DCM Shriram Fine Chemicals Ltd stood at Rs 3.77 crore in Q2 FY26, tumbling by 35.11% year-on-year, and crashing by 183.41% quarter-on-quarter. EBITDA came in at Rs 4 crore, plunging by 36.68% YoY and nosediving by 224.31% sequentially. Total expenses fell by 10.26% to Rs 87.63 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 60.68 crore, posting a minor increase of 6.59% YoY, while employee benefits expense was at Rs 12.21 crore, slipping by 1.61% YoY. For the TTM ended FY26, revenue from operations dropped by 10.38% to Rs 382.64 crore, while net profit tumbled by 118.46% to Rs 3.54 crore, compared to previous TTM. EBITDA soared by 2769% to Rs 0.46 crore, and PBT tanked by 112.12% to Rs 3.14 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 16.07 crore in FY26, as against Rs 14.23 crore in FY25.

Urvashi Tilakdhar acquired 1,79,63,064 equity shares, representing 20.65% of DCM Shriram Fine Chemicals Limited, through an off-market inter-se transfer among promoters on August 1, 2026, according to a filing with the Bombay Stock Exchange and National Stock Exchange. The acquisition, involving shares transferred from Lala Bansi Dhar & Sons (HUF) and Mr. Madhav B Shriram, was described as an inter-family gift out of love and affection.

DCM Shriram Fine Chemicals announced that the 5th Annual General Meeting(AGM) of the company will be held on 14 July 2026.

DCM Shriram Fine Chemicals announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 20%) , subject to the approval of the shareholders.

Net loss of DCM Shriram Fine Chemicals reported to Rs 3.83 crore in the quarter ended March 2026 as against net profit of Rs 4.42 crore during the previous quarter ended March 2025. Sales declined 17.79% to Rs 92.48 crore in the quarter ended March 2026 as against Rs 112.49 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.52 crore in the year ended March 2026 as against net profit of Rs 19.18 crore during the previous year ended March 2025. Sales declined 10.38% to Rs 382.64 crore in the year ended March 2026 as against Rs 426.95 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales92.48112.49 -18 382.64426.95 -10 OPM %-2.716.78 -0.957.70 - PBDT-2.468.14 PL 5.3734.71 -85 PBT-4.525.98 PL -3.1325.91 PL NP-3.834.42 PL -3.5219.18 PL Powered by Capital Market - Live

DCM Shriram Fine Chemicals will hold a meeting of the Board of Directors of the Company on 19 May 2026.